Improving Health, Health Care and Quality of Life

/C O R R E C T I O N -- DaVita Inc./
PRNewswire

In the news release, DaVita Inc. Reports 3rd Quarter 2005 Results, issued earlier today by DaVita Inc. over PR Newswire, in the second table, "CONSOLIDATED STATEMENTS OF CASH FLOWS," on the 36th line, "Purchase of treasury stock," the number "(86,559)" should be under the 2004 column heading rather than the 2005 column heading as incorrectly transmitted by PR Newswire. The corrected table is below:

                  CONSOLIDATED STATEMENTS OF CASH FLOWS
                               (unaudited)
                          (dollars in thousands)

                                                      Nine months ended
                                                        September 30,
                                                     2005           2004
  Cash flows from operating activities:
  Net income                                      $164,494       $165,652
  Adjustments to reconcile net income to cash
   provided by operating activities:
     Depreciation and amortization                  77,080         63,454
     Stock options, principally tax benefits        37,021         30,465
     Minority interests in income of
      consolidated subsidiaries                     18,225         11,345
     Distributions to minority interests           (12,261)        (6,966)
     Deferred income taxes                          (8,950)        11,831
     Refinancing charges                             6,872
     Swap valuation gains                           (4,543)
     Non-cash debt expense                           2,397          1,497
     (Gain) loss on divestitures                    (2,213)            59
     Equity investment income                         (822)        (1,531)
  Changes in operating assets and liabilities,
   other than from acquisitions and divestitures:
     Accounts receivable                           (39,953)       (33,998)
     Medicare lab recoveries                        (1,131)        10,707
     Inventories                                    (2,670)         5,065
     Other current assets                           (2,899)          (755)
     Other long-term assets                         (2,134)         2,109
     Accounts payable                                2,753          7,773
     Accrued compensation and benefits              27,366         22,409
     Other current liabilities                      27,279         43,360
     Income taxes                                   19,670            136
     Other long-term liabilities                    (3,371)            (8)
          Net cash provided by
           operating activities                    302,210        332,604
  Cash flows from investing activities:
     Additions of property and equipment, net      (97,529)       (89,872)
     Acquisitions and divestitures, net           (130,113)      (245,284)
     Investments in and advances to affiliates,
      net                                           14,294          4,862
     Intangible assets                                (779)          (635)
          Net cash used in investing activities   (214,127)      (330,929)
  Cash flows from financing activities:
     Borrowings                                  1,742,433      3,123,171
     Payments on long-term debt                 (1,753,351)    (2,903,648)
     Deferred financing costs                      (30,561)        (3,934)
     Purchase of treasury stock                                   (86,559)
     Stock option exercises                         38,613         34,580
          Net cash (used in) provided by
           financing activities                     (2,866)       163,610
  Net increase in cash and cash equivalents         85,217        165,285
  Cash and cash equivalents at
   beginning of period                             251,979         61,657
  Cash and cash equivalents at end of period      $337,196       $226,942

PRNewswire-FirstCall -- Oct. 31

Photo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO

SOURCE: DaVita Inc.


Contact Investor Relations

For media inquiries, please contact:

Media Kit

Kate Stabrawa
2000 16th Street
Denver, CO 80202
(303) 876-7527